Olanzapine in treatment of patients with bipolar 1 disorder and panic comorbidity: a case study.

ArticleinBosnian journal of basic medical sciences / Udruzenje basicnih mediciniskih znanosti = Association of Basic Medical Sciences 3(4):67-9 · December 2003with1 Read
Impact Factor: 0.44 · Source: PubMed

    Abstract

    Anxiety disorders are frequently co-morbid with bipolar disorders (BP). Anxiety symptoms can have a great impact on course of illness and patient's quality of life. Olanzapine is the first antipsychotic approved as a mood stabilizing agent. In this paper two cases of BP 1 disorder where panic attacks co-occur treated with olanzapine were presented. In both cases olanzapine showed very good effects in treatment of panic symptoms within the course of BP disorder.